Endothelin B receptor antagonists attenuate subarachnoid hemorrhage - Induced cerebral vasospasm

Stroke

Volumn 29, Issue 9, 1998, Pages 1924-1929

  Zuccarello, Mario ^a   Boccaletti, Riccardo ^a   Romano, Alberto ^a   Rapoport, Robert M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Basilar artery; Cerebral ischemia, transient; Endothelins; Vasodilation

Indexed keywords

ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RES 701 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INTRACISTERNAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; SUBARACHNOID HEMORRHAGE;

EID: 0031711765     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.9.1924     Document Type: Article

References (42)

1. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M. A novel endothelin ETA receptor antagonist. BQ-485. and its preventive effect on experimental vasospasm in dogs. Biochem Biophys Res Commun. 1993; 195:969-975.
2. Nirei N, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci. 1993;52:1869-1874.
3. Itoh S, Sasaki T, Asai A, Kuchino Y. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist. BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg. 1994;81:759-764.
4. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC. Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke. 1994;25: 2450-2455.
5. Hino A, Weir BK, Macdonald RL, Thisted RA, Kim CJ, Johns LM. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg. 1995;83:503-509.
6. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol. 1995;277:77-87.
7. Roux S, Loffler B-M, Gray GA, Sprecher U, Clozel M, Clozel J-P. The role of endothelin in experimental cerebral vasospasm. Neurosurgery. 1995;37:78-85.
8. Shigeno T, Clozel M, Sakai S, Saito A, Goto K. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery. 1995;37:87-90.
9. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Stroke. 1996;27:1629-1633.
10. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg. 1996;84: 503-507.
11. Roux S, Breu V, Giller T, Neidhart W, Ramuz H, Coassolo P, Clozel JP, Clozel M. Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther. 1997;283:1110-1118.
12. Edwards R, Trizna W. Response of isolated intracerebral arterioles to ETs. Pharmacology. 1990;41:149-152.
13. Adner M, You J, Edvinsson L. Characterization of ET-A receptors in the cerebral circulation. Neuroreport. 1993;4:441-443.
14. Salom JB, Torregrosa G, Barberá MD, Jover T, Alborch E. ET receptors mediating contraction in goat cerebral arteries. Br J Pharmacol. 1993; 109:826-830.
15. Feger GI, Schilling L, Ehrenreich H, Wahl M. ET-induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123. J Cereb Blood Flow Metab. 1994;14:845-852.
16. Kitazono T, Heistad DD, Faraci FM. Dilatation of the basilar artery in response to selective activation of ET B receptors in vivo. J Pharmacol Exp Ther. 1995;273:1-6.
17. Schilling L, Feger GI, Ehrenreich H, Wahl M. ET-3-induced relaxation of isolated rat basilar artery is mediated by an endothelial ETB-type ET receptor. J Cereb Blood Flow Metab. 1995;15:699-705.
18. Petersson P, Hanson GC, Lindberg BF, Högestätt ED. Contractile effect of big ET-1 and its conversion to ET-1 in rabbit cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:656-661.
19. Nilsson T, Camera L, Adner M, Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery. 1997;40:346-353.
20. Yasuma Y, McCarron RM, Strasser A, Spatz M. The role of ET receptors in postischemic cerebral hypoperfusion. Stroke. 1997;28:258. Abstract.
21. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur J Pharmacol. 1994;259:R1-R2.
22. Hino A, Tokuyama Y, Kobayashi M, Yano M, Weir B, Takeda J, Wang X, Bell GI, Macdonald RL. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab. 1996;16:688-697.
23. Zuccarello M, Romano A, Passalacqua M, Rapoport RM. Endothelin-1-induced endothelin-1 release causes cerebral vasospasm in vivo. J Pharm Pharmacol. 1995;47:702. Letter.
24. Yokokawa K, Kohno M, Yasunari K, Murakawa K, Takeda T. Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension. 1991;18:304-315.
25. Saijonmaa O, Nyman T, Fyhrquist F. Endothelin-1 stimulates its own synthesis in human endothelial cells. Biochem Biophys Res Commun. 1992;188:286-291.
26. Fujitani Y, Oda K, Takimoto M, Inui T, Okada T, Urade Y. Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein. FEBS Lett. 1992;298:79-83.
27. Iwasaki S, Homma T, Matsuda Y, Kon V. Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells. J Biol Chem. 1995;270:6997-7003.
28. Zuccarello M, Boccaletti R, Rapoport RM. Endothelin B1 receptor-mediated endothelin-1 release maintains subarachnoid hemorrhage-induced spasm of rabbit basilar. J Cereb Blood Flow Metab. 1997; 17:S471. Abstract.
29. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective ET B-receptor antagonist. BQ-788. Proc Natl Acad Sci U S A. 1994;91:4892-4896.
30. B2 receptors, BQ-788: effects on blood vessel and small intestine. Biochem Biophys Res Commun. 1994;205:168-173.
31. Karaki H, Sudjarwo SA, Hori M, Tanaka T, Matsuda Y. ET ETB receptor antagonist. RES-701-1: effects on isolated blood vessels and small intestine. Eur J Pharmacol. 1994;262:255-259.
32. Sudjarwo SA, Hori M, Tanaka T, Matsuda Y, Okada T, Karaki H. Subtypes of ET ETA and ETB receptors mediating venous smooth muscle contraction. Biochem Biophys Res Commun. 1994;200:627-633.
33. Tanaka T, Ogawa T, Matsuda Y. Species differences in the binding characteristics of RES-701-1: potent ET ETB receptor-selective antagonist. Biochem Biophys Res Commun. 1995;209:712-716.
34. Bird JE, Waldron TL. Endogenous synthesis of endothelin-1 may mediate a delayed pressor response after injection of endothelin-1 in rats. J Cardiovasc Pharmacol. 1995;25:307-313.
35. B receptor antagonist (PD 145065) and related analogues. Med Chem Res. 1993;3:154-162.
36. He JX, Cody WL, Flynn MA, Welch KM, Reynolds EE, Doherty AM. RES-701-1, synthesis and a reevaluation of its effects on the endothelin receptors. Bioorg Med Chem Lett. 1995;5:621-626.
37. B selective ligands in human and rat heart. Br J Pharmacol. 1996;119:631-636.
38. Katahira R, Shibata K, Yamasaki M, Matsuda Y, Yoshida M. RES-701-1: comparative study of the synthetic and the microbial-origin compounds. Bioorg Med Chem Lett. 1995;5:1595-1600.
39. 2 generation and endothelin-1 release in guinea pigs. Br J Pharmacol. 1996; 118:1397-1402.
40. Matsumura Y, Ikegawa R, Suzuki Y, Takaoka M, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe M, Morimoto S. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci. 1991;49:841-848.
41. Caner HH, Kwan A-L, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg. 1996;85:917-922.
42. Kwan AL, Bavbek M, Jeng AY, Maniara W, Toyoda T, Lappe RW, Kassell NF, Lee KS. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg. 1997;87: 281-286.